Literature DB >> 30958728

Targeted TNF-α Overexpression Drives Salivary Gland Inflammation.

A Limaye1, B E Hall1, L Zhang2, A Cho1, M Prochazkova1, C Zheng1, M Walker3, F Adewusi4, P D Burbelo1, Z J Sun2, I S Ambudkar1, J C Dolan5, B L Schmidt5, A B Kulkarni1.   

Abstract

Chronic inflammation of the salivary glands from pathologic conditions such as Sjögren's syndrome can result in glandular destruction and hyposalivation. To understand which molecular factors may play a role in clinical cases of salivary gland hypofunction, we developed an aquaporin 5 (AQP5) Cre mouse line to produce genetic recombination predominantly within the acinar cells of the glands. We then bred these mice with the TNF-αglo transgenic line to develop a mouse model with salivary gland-specific overexpression of TNF-α; which replicates conditions seen in sialadenitis, an inflammation of the salivary glands resulting from infection or autoimmune disorders such as Sjögren's syndrome. The resulting AQP5-Cre/TNF-αglo mice display severe inflammation in the salivary glands with acinar cell atrophy, fibrosis, and dilation of the ducts. AQP5 expression was reduced in the salivary glands, while tight junction integrity appeared to be disrupted. The immune dysregulation in the salivary gland of these mice led to hyposalivation and masticatory dysfunction.

Entities:  

Keywords:  acinar cells; aquaporin 5; sialadenitis; tight junctions; transgenic mouse; xerostomia

Year:  2019        PMID: 30958728      PMCID: PMC6535923          DOI: 10.1177/0022034519837240

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  33 in total

1.  Cre stoplight: a red/green fluorescent reporter of Cre recombinase expression in living cells.

Authors:  Y S Yang; T E Hughes
Journal:  Biotechniques       Date:  2001-11       Impact factor: 1.993

2.  Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome.

Authors:  H Koski; A Janin; M G Humphreys-Beher; T Sorsa; M Malmström; Y T Konttinen
Journal:  Clin Exp Rheumatol       Date:  2001 Mar-Apr       Impact factor: 4.473

3.  Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients.

Authors:  S Steinfeld; E Cogan; L S King; P Agre; R Kiss; C Delporte
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

4.  Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

Authors:  Xavier Mariette; Philippe Ravaud; Serge Steinfeld; Gabriel Baron; Joelle Goetz; Eric Hachulla; Bernard Combe; Xavier Puéchal; Yvon Pennec; Bernard Sauvezie; Aleth Perdriger; Gilles Hayem; Anne Janin; Jean Sibilia
Journal:  Arthritis Rheum       Date:  2004-04

5.  The difference of aquaporin 5 distribution in acinar and ductal cells in lacrimal and parotid glands.

Authors:  Yasumasa Sasaki; Kazuo Tsubota; Jitesh D Kawedia; Anil G Menon; Masato Yasui
Journal:  Curr Eye Res       Date:  2007-11       Impact factor: 2.424

6.  Rat aquaporin-5 4.3-kb 5'-flanking region differentially regulates expression in salivary gland and lung in vivo.

Authors:  Beiyun Zhou; David K Ann; Per Flodby; Parviz Minoo; Janice M Liebler; Edward D Crandall; Zea Borok
Journal:  Am J Physiol Cell Physiol       Date:  2008-04-30       Impact factor: 4.249

7.  Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome.

Authors:  P Oxholm; T E Daniels; K Bendtzen
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

8.  Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands.

Authors:  Seshagiri R Nandula; Shoba Amarnath; Alfredo Molinolo; Bidhan C Bandyopadhyay; Bradford Hall; Corinne M Goldsmith; Changyu Zheng; Jonas Larsson; Taduru Sreenath; WanJun Chen; Indu S Ambudkar; Stefan Karlsson; Bruce J Baum; Ashok B Kulkarni
Journal:  Arthritis Rheum       Date:  2007-06

9.  Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.

Authors:  N M Moutsopoulos; G E Katsifis; N Angelov; R A Leakan; V Sankar; S Pillemer; S M Wahl
Journal:  Ann Rheum Dis       Date:  2008-01-15       Impact factor: 19.103

10.  A global double-fluorescent Cre reporter mouse.

Authors:  Mandar Deepak Muzumdar; Bosiljka Tasic; Kazunari Miyamichi; Ling Li; Liqun Luo
Journal:  Genesis       Date:  2007-09       Impact factor: 2.487

View more
  10 in total

1.  Salivary exosomes as a new therapy to ameliorate diabetes mellitus and combat xerostomia and submandibular salivary glands dysfunction in diabetic rats.

Authors:  Zeinab A Salem; Amany Hany Mohamed Kamel; Nermeen AbuBakr
Journal:  J Mol Histol       Date:  2021-01-03       Impact factor: 2.611

2.  Ruscogenin Ameliorated Sjögren's Syndrome by Inhibiting NLRP3 Inflammasome Activation.

Authors:  Jing He; Yue Wang; Lei Xu; Changsong Xu; Yamei Zhu; Meimei Xu; Yueyue Chen; Liang Guo; Wei Hu; Dake Xu; Rongyue Jing; Bo Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-28       Impact factor: 2.650

Review 3.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

4.  A Novel Experimental Approach for In Vivo Analyses of the Salivary Gland Microvasculature.

Authors:  Bernd Uhl; Constanze Braun; Julian Dominik; Joshua Luft; Martin Canis; Christoph A Reichel
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

Review 5.  Insight into Salivary Gland Aquaporins.

Authors:  Claudia D'Agostino; Osama A Elkashty; Clara Chivasso; Jason Perret; Simon D Tran; Christine Delporte
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

6.  Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sjögren's Syndrome.

Authors:  Jeremy Kiripolsky; Rose-Anne Romano; Eileen M Kasperek; Guan Yu; Jill M Kramer
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

7.  IL-17 drives salivary gland dysfunction via inhibiting TRPC1-mediated calcium movement in Sjögren's syndrome.

Authors:  Fan Xiao; Wenhan Du; Xiaoxia Zhu; Yuan Tang; Lixiong Liu; Enyu Huang; Chong Deng; Cainan Luo; Man Han; Ping Chen; Liping Ding; Xiaoping Hong; Lijun Wu; Quan Jiang; Hejian Zou; Dongzhou Liu; Liwei Lu
Journal:  Clin Transl Immunology       Date:  2021-04-29

8.  Molecular Mechanism of Sphingosine-1-Phosphate Receptor 1 Regulating CD4+ Tissue Memory in situ T Cells in Primary Sjogren's Syndrome.

Authors:  Xiao-Xiao Yang; Chao Yang; Li Wang; Ying-Bo Zhou; Xiang Yuan; Nan Xiang; Yi-Ping Wang; Xiao-Mei Li
Journal:  Int J Gen Med       Date:  2021-09-27

9.  Advances in Pathogenesis of Sjögren's Syndrome.

Authors:  Yao Tian; Hongyi Yang; Na Liu; Yan Li; Jie Chen
Journal:  J Immunol Res       Date:  2021-10-07       Impact factor: 4.818

10.  Inhibition of Alk signaling promotes the induction of human salivary-gland-derived organoids.

Authors:  Shohei Yoshimoto; Junko Yoshizumi; Hiromasa Anzai; Koichiro Morishita; Kazuhiko Okamura; Akimitsu Hiraki; Shuichi Hashimoto
Journal:  Dis Model Mech       Date:  2020-09-28       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.